Return to content in this issue

Mepolizumab for the treatment of eosinophilic cystitis: reply

Trefond L^1,2 Kahn JE<sup>3


1</sup>Service de Médecine Interne, CHU Gabriel Montpied, Clermont-Ferrand, France
²Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 1382, ClermontFerrand, France
³National Reference Center for Hypereosinophilic Syndromes, CEREO, France; Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise Paré Hospital, Boulogne-Billancourt, France

J Investig Allergol Clin Immunol 2024; Vol. 34(4)
doi: 10.18176/jiaci.0980